Skip to content

Cognitive

Cortexin

InjectableEvidence BEvery day
Half-life
variesby component
Typical vial
5 / 10mg
Research amounts
5–10mg

per administration

Common schedule
Every day
Some human use

It has been used in people, but no trial has settled how much or how often.

Licensed as a medicine in Russia.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 200 units loaded200units dialled
Concentration
2.5mg/mL
Volume per draw
2mL
Units to dial
200
Doses per cartridge
1

This is 200 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.

Dial range varies by pen; 1–60 units is the common configuration.

Vial label

Copy this into your label printer.

Published research contexts for Cortexin describe 510 mg per administration. Descriptive only, not a recommendation.

Like Cerebrolysin, a mixture of low-molecular-weight cortical polypeptides rather than a single molecule, so no single elimination half-life describes it and none is modelled.

Licensed as a medicine in Russia, where the lyophilised powder is reconstituted and given as an intramuscular injection. Like Cerebrolysin it is a mixture of low-molecular-weight cortical polypeptides rather than a single molecule, and no Western dose-ranging trial fixes a schedule, so no schedule table is shown.

Where these numbers come from

  • Russian Cortexin neuropeptide literatureA bovine/porcine cortical polypeptide fraction; most evidence is Russian-language clinical and preclinical work, with no Western dose-ranging trial.

Next steps